Eric Ostertag
Founder presso Demeetra AgBio, Inc.
Patrimonio netto: 19 M $ in data 31/03/2024
Profilo
Eric M.
Ostertag is the founder of Transposagen Biopharmaceuticals, Inc. (founded in 2003), Vindico NanoBioTechnology LLC (founded in 2008), PhenoTech, Inc. (founded in 2003), and Poseida Therapeutics, Inc. (founded in 2014).
He held the position of President & Chief Executive Officer at Transposagen Biopharmaceuticals, Inc. and Vindico NanoBioTechnology LLC, and Executive Vice President-Research at PhenoTech, Inc. Currently, he is a Director at Hera Testing Laboratories, Inc. Dr. Ostertag received a doctorate degree from the University of Pennsylvania in 2002 and an undergraduate degree from the University of Wisconsin in 1995.
Dr. Ostertag is also the founder of Hera BioLabs, Demeetra AgBio, Inc.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
15/03/2023 | 6 028 560 ( 6.25% ) | 19 M $ | 31/03/2024 |
Posizioni attive di Eric Ostertag
Società | Posizione | Inizio |
---|---|---|
Hera Testing Laboratories, Inc.
Hera Testing Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Hera Testing Laboratories, Inc. develops preclinical drugs for vivo and vitro toxicology. The company was founded in 2014 and is headquartered in Lexington, KY. | Director/Board Member | - |
Hera BioLabs
Hera BioLabs Miscellaneous Commercial ServicesCommercial Services Hera BioLabs is a preclinical service and technology provider that offers genetic engineering and animal model creation technologies. Hera conducts all work with excellent scientific rigor and customer service at their laboratories, which include an AAALAC-accredited state-of-the-art vivarium, centrally located in Kentucky. The American company created the SRG™ rat, the first commercially available highly immunocompromised rat model validated for human tumor xenograft studies. Hera has its own proprietary genetic engineering technologies, the PiggyBac® DNA delivery system and the Cas-CLOVER™ site-specific nuclease system platforms used for cell line modification and animal model creation. The company provides researchers in industry and academia with genetic engineering technologies and related products, as well as services in these areas, performing cell engineering and in vitro and in vivo oncology studies for clients. The company was founded by Eric M. Ostertag. | Founder | - |
Demeetra AgBio, Inc.
Demeetra AgBio, Inc. Miscellaneous Commercial ServicesCommercial Services Demeetra AgBio, Inc. is an American biotechnology company that specializes in gene editing. Demeetra AgBio is located in a hub for agbiotech and is centrally located in the bluegrass state. The company has built extensive gene editing know-how and has a scientific team composed of experts with diverse backgrounds in gene editing. The company's scientific achievements include being the first to successfully edit plants and yeast with their precise cas-clover technology. Demeetra AgBio's primary focus is on engineering traits for life with advanced gene-editing technologies cas-clover & piggybac transposase. The company was founded in 2019 by Eric M. Ostertag and is currently led by CEO Jack Crawford. | Founder | - |
Precedenti posizioni note di Eric Ostertag
Società | Posizione | Fine |
---|---|---|
POSEIDA THERAPEUTICS, INC. | Chief Executive Officer | 01/02/2022 |
Transposagen Biopharmaceuticals, Inc.
Transposagen Biopharmaceuticals, Inc. BiotechnologyHealth Technology Transposagen Biopharmaceuticals, Inc. operates as a biotechnology company. Its products and services include piggyBac Reagents, cell engineering services and gene editing reagents & kits. The company was founded by Ostertag M. Eric in 2005 and is headquartered in Lexington, KY. | Chief Executive Officer | 01/07/2015 |
Vindico NanoBioTechnology LLC
Vindico NanoBioTechnology LLC BiotechnologyHealth Technology Vindico NanoBioTechnology LLC develops novel and life-saving therapies. The company is headquartered in San Diego, CA. | Chief Executive Officer | 01/07/2015 |
PhenoTech, Inc.
PhenoTech, Inc. BiotechnologyHealth Technology PhenoTech, Inc. develops and markets monoclonal antibodies which are used in blood diagnostic and therapeutic applications. It offers blood diagnostic reagents, such as nanoscale emissive antibody-complexes for typing reagents for pre-transfusion testing. The company was founded by Eric Ostertag in 2003 and is headquartered in Philadelphia, PA. | Founder | 01/01/2007 |
Formazione di Eric Ostertag
University of Pennsylvania | Doctorate Degree |
University of Wisconsin | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
POSEIDA THERAPEUTICS, INC. | Health Technology |
Aziende private | 6 |
---|---|
Transposagen Biopharmaceuticals, Inc.
Transposagen Biopharmaceuticals, Inc. BiotechnologyHealth Technology Transposagen Biopharmaceuticals, Inc. operates as a biotechnology company. Its products and services include piggyBac Reagents, cell engineering services and gene editing reagents & kits. The company was founded by Ostertag M. Eric in 2005 and is headquartered in Lexington, KY. | Health Technology |
Hera Testing Laboratories, Inc.
Hera Testing Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Hera Testing Laboratories, Inc. develops preclinical drugs for vivo and vitro toxicology. The company was founded in 2014 and is headquartered in Lexington, KY. | Health Technology |
Vindico NanoBioTechnology LLC
Vindico NanoBioTechnology LLC BiotechnologyHealth Technology Vindico NanoBioTechnology LLC develops novel and life-saving therapies. The company is headquartered in San Diego, CA. | Health Technology |
PhenoTech, Inc.
PhenoTech, Inc. BiotechnologyHealth Technology PhenoTech, Inc. develops and markets monoclonal antibodies which are used in blood diagnostic and therapeutic applications. It offers blood diagnostic reagents, such as nanoscale emissive antibody-complexes for typing reagents for pre-transfusion testing. The company was founded by Eric Ostertag in 2003 and is headquartered in Philadelphia, PA. | Health Technology |
Hera BioLabs
Hera BioLabs Miscellaneous Commercial ServicesCommercial Services Hera BioLabs is a preclinical service and technology provider that offers genetic engineering and animal model creation technologies. Hera conducts all work with excellent scientific rigor and customer service at their laboratories, which include an AAALAC-accredited state-of-the-art vivarium, centrally located in Kentucky. The American company created the SRG™ rat, the first commercially available highly immunocompromised rat model validated for human tumor xenograft studies. Hera has its own proprietary genetic engineering technologies, the PiggyBac® DNA delivery system and the Cas-CLOVER™ site-specific nuclease system platforms used for cell line modification and animal model creation. The company provides researchers in industry and academia with genetic engineering technologies and related products, as well as services in these areas, performing cell engineering and in vitro and in vivo oncology studies for clients. The company was founded by Eric M. Ostertag. | Commercial Services |
Demeetra AgBio, Inc.
Demeetra AgBio, Inc. Miscellaneous Commercial ServicesCommercial Services Demeetra AgBio, Inc. is an American biotechnology company that specializes in gene editing. Demeetra AgBio is located in a hub for agbiotech and is centrally located in the bluegrass state. The company has built extensive gene editing know-how and has a scientific team composed of experts with diverse backgrounds in gene editing. The company's scientific achievements include being the first to successfully edit plants and yeast with their precise cas-clover technology. Demeetra AgBio's primary focus is on engineering traits for life with advanced gene-editing technologies cas-clover & piggybac transposase. The company was founded in 2019 by Eric M. Ostertag and is currently led by CEO Jack Crawford. | Commercial Services |
- Borsa valori
- Insiders
- Eric Ostertag